MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.
1Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB-742F, Boston, MA 02115, USA.
Cardiovascular Research
|May 16, 2017
Summary
MicroRNAs regulate gene expression in adipose tissue. Dysfunctional microRNAs are linked to obesity, inflammation, and cardiovascular diseases, offering potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Science
Background:
- Adipose tissue dysfunction is implicated in metabolic and cardiovascular diseases.
- MicroRNAs (non-coding RNAs regulating gene expression) are increasingly recognized for their role in adipose tissue biology.
- Dysregulation of microRNAs in adipose tissue is linked to various pathologies.
Purpose of the Study:
- To review the role of microRNAs in adipose tissue differentiation and function.
- To explore the implications of microRNA dysregulation in obesity, inflammation, and cardiovascular diseases.
- To discuss therapeutic strategies targeting microRNAs for cardiovascular conditions.
Main Methods:
- Literature review of studies on microRNAs in adipose tissue.
- Analysis of microRNA involvement in white, brown, and beige adipose tissue.
- Examination of microRNA dysregulation in human diseases.
Main Results:
- MicroRNAs play critical roles in adipocyte differentiation and function.
- Adipocyte-derived microRNAs can serve as biomarkers for cardiometabolic diseases.
- MicroRNAs from adipose tissue can influence gene expression in other organs.
Conclusions:
- MicroRNA dysregulation in adipose tissue is a significant factor in obesity and cardiovascular disease.
- Adipocyte microRNAs hold promise as diagnostic biomarkers and therapeutic targets.
- Further research is needed to develop effective microRNA-based therapies for cardiovascular diseases.
